Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the …
JH Traverse, TD Henry, SG Ellis, CJ Pepine… - Jama, 2011 - jamanetwork.com
Context Clinical trial results suggest that intracoronary delivery of autologous bone marrow
mononuclear cells (BMCs) may improve left ventricular (LV) function when administered
within the first week following myocardial infarction (MI). However, because a substantial
number of patients may not present for early cell delivery, the efficacy of autologous BMC
delivery 2 to 3 weeks post-MI warrants investigation. Objective To determine if intracoronary
delivery of autologous BMCs improves global and regional LV function when delivered 2 to …
mononuclear cells (BMCs) may improve left ventricular (LV) function when administered
within the first week following myocardial infarction (MI). However, because a substantial
number of patients may not present for early cell delivery, the efficacy of autologous BMC
delivery 2 to 3 weeks post-MI warrants investigation. Objective To determine if intracoronary
delivery of autologous BMCs improves global and regional LV function when delivered 2 to …